Roundhill ETF Trust Roundhill Humanoid Robotics ETF (BATS: HUMN)

Ultime notizie per Roundhill ETF Trust Roundhill Humanoid Robotics ETF (BATS:HUMN)

To achieve its investment objective by investing in the equity securities of Humanoid Robotics Companies (as defined below). Humanoid robotics refers to the field of designing and building robots that resemble and function similarly to humans. Humanoid robots typically have a human-like structure, including a head, torso, arms and legs, and are equipped with advanced sensors, artificial intelligence and actuators to interact with their environment in a human-like manner.

Tesla, Inc.

Nvidia Corp.

Ubtech Robotics Corp Ltd

Xpeng Inc

Xiaomi Corp

Hyundai Motor Co

Hexagon Ab

Roundhill Humanoid Robotics ETF

Roundhill ETF Trust Roundhill Humanoid Robotics ETF

Citigroup analyst Steven Enders maintains Intapp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTA#NASDAQ">INTA</a>) with a Neutral and lowers the price target from $66 to $53.

News

Price Target

Analyst Ratings

INTA

Citigroup Maintains Neutral on Intapp, Lowers Price Target to $53

Stifel analyst David Grossman maintains IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) with a Buy and raises the price target from $290 to $310.

Stifel Maintains Buy on IBM, Raises Price Target to $310

Stifel analyst Stephen Gengaro maintains Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) with a Buy and lowers the price target from $32 to $31.

Stifel Maintains Buy on Halliburton, Lowers Price Target to $31

Rumors

IPOs

AUGO

Aura Minerals IPO Indicating $23.30/Share On 151K Shares; IPO Priced At $24.25/Share On ~8.1M Shares

Many people work hard for several years or decades to reach a seven-figure portfolio. However, <a href="https://www.reddit.com/r/HENRYfinance/comments/1lu8y0u/tips_on_motivation_to_get_from_1m_to_2m/">some people get comfortable</a> after reaching a $1 million net worth and stagnate. A bunch of millionaires discussed this phenomenon on Reddit and shared how they stay disciplined after reaching the $1 million mark.
"Now I find myself relaxing," one millionaire mentioned while looking for some guidance. The original poster has a $1 million net worth but hasn't been hustling as hard to turn it into $2 million.
These were some of the suggestions.
Don't Miss:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
<h2 class="wp-block-heading">$1 Million Isn't What It Used To Be</h2>
Several Redditors rushed to the comments section to mention that $1 million isn't what it used to be. In many neighborhoods, $1 million is not enough to buy a large house. Most people cannot retire on $1 million due to the rising cost of goods and services.
Keeping this fact in perspective can help you work toward a more ambitious goal, such as a $5 million to $10 million net worth. Many Redditors mentioned that this is the sweet spot for feeling rich. Not everyone gets to $1 million, but if you are already there and want to retire on your terms, it's worth setting your sights on $5 million to $10 million.
A more ambitious target can also result in more action. If you have a $1 million portfolio and will feel content with $1.1 million, there isn't much of an incentive to make any additional effort. The stock market can get you there in less than a year if it's bullish. However, if you want a net worth that ranges from $5 million to $10 million, you will have more motivation to go from $1 million to $2 million.
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">Time Is Your Friend Due To Compound Growth</h2>
One Redditor mentioned that every $1 million gets easier over time. It's very hard to go from $0 to $1 million. However, you only need your portfolio to double to reach $2 million. That can happen within a decade, depending on your investments. However, you can also retain the good financial habits that turned you into a millionaire, such as making regular contributions to your portfolio.
Then, you only have to grow your portfolio by 50% to go from $2 million to $3 million. The jump from $3 million to $4 million only requires a 33% boost. Every million gets easier over time, but you must remain financially disciplined. Compound growth can work in your favor, but if you balloon your lifestyle as your net worth grows, you can negate all of the positive effects of a high income and a seven-figure portfolio.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
<h2 class="wp-block-heading">Get Out Of Trading Time For Money</h2>
One Redditor laid out a clear motivation that can help anyone avoid being content with their current net worth. The same Redditor also criticized the original poster for asking random people on the internet for motivation. The commenter then shared their thoughts.
"The motivation for 2, 3, 4, etc. million is being able to own your time and be in the driver seat, not be stuck with some commitment to keep trading time for money," the Redditor explained.
Most people build nest eggs and make prudent financial decisions so they can live life on their terms. Financial flexibility makes it easier to take risks, such as starting a business or working on a side hustle. Those risks can help you become financially free, especially if your portfolio is growing behind the scenes.&nbsp;
Consider what you don't have right now that you can have if you reach a $2 million net worth. Then, apply the same exercise for the $5 million to $10 million sweet spot that some Redditors mentioned. This exercise can give you the necessary motivation to put in the work and stay disciplined.
Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Image: Shutterstock

Personal Finance

Millionaires Discuss How To Stay Motivated After Reaching A $1 Million Net Worth: 'Now I Find Myself Relaxing'

Citigroup analyst Steven Enders maintains BlackLine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BL#NASDAQ">BL</a>) with a Buy and raises the price target from $58 to $67.

Citigroup Maintains Buy on BlackLine, Raises Price Target to $67

On Wednesday, AstraZeneca Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">Phase 3 program</a>.
The trial showed that anselamimab, a light chain depleter antibody, did not achieve statistical significance for the primary endpoint compared to placebo in patients with Mayo stages IIIa and IIIb light chain (AL) amyloidosis.
The primary endpoint was a hierarchical combination of time to all-cause mortality (ACM) and frequency of cardiovascular hospitalizations (CVH). All patients in the clinical program received a background standard of care for plasma cell dyscrasia.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/contracts/25/07/46249640/astrazeneca-in-15b-talks-for-drug-that-could-upend-lung-cancer-treatment" rel="noreferrer noopener">AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment</a>
Anselamimab <a target="_blank" href="https://www.astrazeneca.com/media-centre/press-releases/2025/update-on-anselamimab-in-al-amyloidosis.html" rel="noreferrer noopener">showed</a> highly clinically meaningful improvement in time to ACM and frequency of CVH in a prespecified subgroup of patients, compared to placebo.
Light chain (AL) amyloidosis is a systemic and progressive type of amyloidosis in which immunoglobulin light chain proteins are abnormally produced by defective plasma cells in the bone marrow.
These abnormal proteins misfold, aggregate and form amyloid fibrils that deposit and accumulate in tissues or organs, particularly in the heart and kidneys. Worldwide, an estimated 74,000 patients are living with AL amyloidosis.
Anselamimab was well tolerated, with most events balanced between the anselamimab treatment arm and the placebo arm. Evaluation of full results is ongoing to further characterise the efficacy and safety of anselamimab.
In other clinical news this week, AstraZeneca also announced positive topline data on Monday, July 14, from the BaxHTN <a target="_blank" href="https://www.benzinga.com/news/health-care/25/07/46390982/astrazenecas-drug-shows-promise-for-resistant-hypertension-in-phase-3-trial" rel="noreferrer noopener">Phase 3 trial for baxdrostat</a>.
This investigational oral aldosterone synthase inhibitor is being developed for patients with uncontrolled or treatment-resistant hypertension.
The trial demonstrated that baxdrostat, at both 2mg and 1mg doses, achieved a statistically significant and clinically meaningful reduction in mean seated systolic blood pressure (SBP) compared to placebo at 12 weeks.
This success is particularly noteworthy as uncontrolled and resistant hypertension remain significant public health challenges, with many patients struggling to achieve blood pressure goals despite multiple medications.
Baxdrostat aims to address this unmet need by targeting aldosterone dysregulation, a key contributor to hard-to-control hypertension.
Further solidifying its research and development pipeline, AstraZeneca entered a strategic research collaboration in June with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited.
This partnership aims to leverage CSPC&#8217;s AI-driven drug discovery platform to accelerate the discovery and development of novel oral candidates for multiple high-priority targets.
The collaboration specifically focuses on chronic indications, including a preclinical small-molecule oral therapy for <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45924585/astrazeneca-inks-research-pact-with-chinas-cspc-pharmaceuticals-focused-on-ai-driven-research-valued-up-to-5-33-billion" rel="noreferrer noopener">immunological diseases</a>.
Price Action: AZN stock is trading lower by 0.30% to $70.11 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46435899/trumps-pharma-tariffs-can-hit-novo-nordisk-says-barclays-expert-but-its-difficult-to-predict-as-drugmakers-have-complex-supply-chains" target="_blank" rel="noreferrer noopener">Trump&#8217;s Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It&#8217;s &#8216;Difficult&#8217; To Predict As Drugmakers Have &#8216;Complex Supply Chains&#8217;</a></li>
</ul>
Photo by Piotr Swat via Shutterstock

Biotech

Large Cap

Health Care

General

AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition

WIIM

Aptorum Group shares are trading higher after the company announced it entered into an all-stock merger agreement with DiamiR. DiamiR Biosciences will retain its name and become a wholly-owned subsidiary of Aptorum Group.

Apollo Asset Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) has outperformed the market over the past 5 years by 9.11% on an annualized basis producing an average annual return of 22.99%. Currently, Apollo Asset Management has a market capitalization of $85.96 billion. 
Buying $100 In APO: If an investor had bought $100 of APO stock 5 years ago, it would be worth $291.39 today based on a price of $150.41 for APO at the time of writing.
<h3>Apollo Asset Management's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752677110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Apollo Asset Management 5 Years Ago Would Be Worth This Much Today

<a href="https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests">https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests</a>

CMPS

CYBN

DRUG

ENVB

MNMD

Reported Earlier: 'The key to living longer could be tied to a surprising substance, study suggests'- Fox News

PPL Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPL#NYSE">PPL</a>) shares saw modest gains in early Wednesday trading following the announcement of a strategic partnership with Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) to develop new gas-powered energy facilities tailored for<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> data center operations.</a>
The two firms <a href="https://www.prnewswire.com/news-releases/ppl-corporation-and-blackstone-infrastructure-create-joint-venture-to-build-natural-gas-generation-in-pennsylvania-in-support-of-data-center-development-302505948.html" target="_blank" rel="noreferrer noopener">unveiled </a>a joint venture aimed at designing, constructing and operating combined-cycle natural gas plants across Pennsylvania. The facilities will deliver power to data centers under long-term energy service agreements (ESAs), offering stable returns while minimizing exposure to volatile merchant energy pricing.
Also Read: <a target="_blank" href="https://www.benzinga.com/insights/options/25/07/46353176/blackstones-options-frenzy-what-you-need-to-know" rel="noreferrer noopener">Blackstone&#8217;s Options Frenzy: What You Need to Know</a>
Vincent Sorgi, CEO of PPL, highlighted that this collaboration leverages the strengths of both entities to meet the growing energy demands of the digital economy.
&#8220;We&#8217;re excited to leverage the powerful expertise that PPL and Blackstone Infrastructure possess to bring much-needed new dispatchable generation online in Pennsylvania to match new data center load in a way that directly supports economic development and large load customer needs, helps to mitigate rising electricity prices for energy consumers, and delivers increased value for shareowners without traditional merchant power risk,&#8221; Sorgi said during the Pennsylvania Energy and Innovation Summit in Pittsburgh.
Blackstone Infrastructure will hold a 49% stake in the joint entity, with PPL retaining a 51% controlling interest. Both partners will share costs and profits proportionally.
The project will focus on locations near the Marcellus and Utica shale formations, leveraging existing pipeline access and the region&#8217;s strong interest in data centers.
PJM Interconnection has warned of potential energy shortfalls by 2026 due to aging infrastructure and surging demand from data-intensive industries, such as AI.
In PPL&#8217;s own utility service area, developers have proposed more than 60 gigawatts of data center projects, including 13 GW in advanced planning. PPL forecasts a 6 GW capacity gap in five to six years, equivalent to roughly $15 billion in new investment needs.
While the joint venture represents a major step toward ensuring sufficient generation capacity, PPL noted that broader legislative action is still required. Pending bills in the Pennsylvania legislature aim to allow utilities to invest in and operate generation assets again, potentially unlocking further energy development across the state.
Pennsylvania Gov. Josh Shapiro praised the announcement, calling it a key investment in both infrastructure and job creation.
&#8220;Pennsylvania is competing again,&#8221; he said, citing the state&#8217;s diverse energy resources and role in driving technological advancement.
Price Action: PPL shares are trading higher by 0.40% to $35.49 premarket at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/07/46440085/gitlab-bets-big-on-ai-code-explosion-and-wall-streets-buying-in" target="_blank" rel="noreferrer noopener">GitLab Bets Big On AI Code Explosion — And Wall Street&#8217;s Buying In</a></li>
</ul>
Photo: Shutterstock

Equities

Markets

Movers

Tech

PPL And Blackstone Join Forces To Build Gas Plants For Data Centers

BMNR

BitMine Immersion Technologies shares are trading higher after a 13G filing showed Peter Thiel–linked FF Consumer Growth disclosed a 9.1% stake in the company as of July 8, 2025.

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) with a Buy and lowers the price target from $22 to $9.

BMEA

Citigroup Maintains Buy on Biomea Fusion, Lowers Price Target to $9

Global Payments shares are trading higher after the Financial Times reported that Elliott Management has built a stake in the company.

Reuters Cites Transportation Secretary Duffy Saying Trump Administration Needs Another $19B To Fully Revamp Air Traffic Control Operations

Citigroup analyst Ariel Rosa maintains JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) with a Buy and lowers the price target from $175 to $170.

JBHT

Citigroup Maintains Buy on JB Hunt Transport Servs, Lowers Price Target to $170

Macro Economic Events

Global

Economics

iShares MSCI Israel Capped Investable Market Index Fund

Reuters Reports Syrian Druze Religious Leader Saying They Reached Ceasefire Agreement With Syrian Government

Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) shares are trading higher Wednesday after the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its <a href="https://www.benzinga.com/pressreleases/25/07/b46439193/tempus-receives-u-s-fda-510-k-clearance-for-tempus-ecg-low-ef-software">ejection fraction software</a>.
What Happened: Tempus said the FDA granted it 510(k) clearance for its Tempus ECG-Low EF software, which uses AI to identify patients with a potential left ventricular ejection fraction. 
Ejection fraction measures the percentage of blood that the heart pumps out with each beat. The ECG-AI device is Tempus AI&#8217;s second FDA-cleared device.
&#8220;With Tempus ECG-Low EF, we&#8217;re adding another powerful tool to the hands of clinicians to help them identify patients at risk for serious cardiovascular conditions much earlier in their care journey,&#8221; said Brandon Fornwalt, senior vice president of Cardiology at Tempus AI.
&#8220;Detection of LVEF is essential for undiagnosed patients, and this technology enables us to deliver that capability at scale to transform patient care.&#8221;
<h3 class="wp-block-heading">How To Buy TEM Stock</h3>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Tempus AI's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
TEM Price Action: <a href="http://benzinga.com/quote/tem">Tempus AI shares </a>were up 4.8% at $58.58 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46435552/larry-ellison-surges-past-mark-zuckerberg-to-become-worlds-second-richest-person-as-oracles-ai-deals-with-openai-us-government-drive-massive-stock-surge">Larry Ellison Surges Past Mark Zuckerberg To Become World&#8217;s Second-Richest Person As Oracle&#8217;s AI Deals With OpenAI, US Government Drive Massive Stock Surge</a></li>
</ul>
Photo: Piotr Swat/Shutterstock.com

Tempus AI Stock Is Rising Wednesday: What's Happening?

Stifel analyst Jeffrey Stantial maintains Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) with a Buy and raises the price target from $315 to $353.

FLUT

Stifel Maintains Buy on Flutter Entertainment, Raises Price Target to $353

Shares of Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) are trading lower Wednesday morning. The continued selling pressure follows a two-day slide that erased some recent gains, leaving investors to weigh long-term growth against near-term financing pressures.
What To Know: The recent downturn was triggered by a July 9 prospectus filing for the potential resale of up to <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46398722/plug-powers-hot-streak-stalls-as-wall-street-frets-over-warrant-surprise">31.5 million shares</a> by a selling stockholder. While Plug Power will not receive proceeds, the filing stoked investor concerns over share dilution, contributing to a pullback that began Monday.
This pressure countered a rally fueled by <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46423504/plug-power-stock-is-sliding-tuesday-whats-going-on">positive developments</a>. Plug recently secured an expanded, lower-cost hydrogen supply agreement through 2030, which CEO Andy Marsh highlighted as a &#8220;win for… our margin profile.&#8221; 
Sentiment was also boosted by President Donald Trump signing the &#8220;One Big Beautiful Bill,&#8221; which extended the 45V clean hydrogen tax credit by two years.
Further bolstering the bull case, CFO Paul Middleton <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46120866/whats-going-on-with-plug-power-stock-12">purchased</a> 650,000 shares in June, signaling strong executive confidence in the company&#8217;s trajectory. Currently, investors appear to be balancing these strategic wins and insider confidence against the potential dilution, resulting in Wednesday&#8217;s downward trading action.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, Plug Power presents a mixed quantitative profile. The system, which scores stocks on four key factors, gives Plug a very low Momentum score of 7.75 and a low Growth score of 15.33, suggesting weak recent price performance and lagging fundamental growth compared to its peers.
However, the stock stands out with a very high Value score of 75.09. This indicates that despite its poor momentum and growth metrics, the stock may be considered undervalued based on its current price relative to its fundamental financial data.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Plug shares are trading lower by 1.16% to $1.52 Wednesday morning. The stock has a 52-week high of $3.34 and a 52-week low of 69 cents.
<h2 class="wp-block-heading">How To Buy PLUG Stock</h2>
By now you're likely curious about how to participate in the market for Plug Power &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Plug Power, which is trading at $1.53 as of publishing time, $100 would buy you 65.36 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46442422/cisco-is-quietly-beating-the-ai-hype-should-investors-pay-closer-attention">Cisco Is Quietly Beating The AI Hype—Should Investors Pay Closer Attention?</a></li>
</ul>
Image: Shutterstock

Comments

Roundhill ETF Trust Roundhill Humanoid Robotics ETF

Notizie

Ultime notizie per Roundhill ETF Trust Roundhill Humanoid Robotics ETF (BATS:HUMN)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO